165 related articles for article (PubMed ID: 36323190)
1. Type I and II interferon signaling in colorectal cancer liver metastasis.
Mödl B; Moritsch S; Zwolanek D; Eferl R
Cytokine; 2023 Jan; 161():156075. PubMed ID: 36323190
[TBL] [Abstract][Full Text] [Related]
2. Highly-metastatic colorectal cancer cell released miR-181a-5p-rich extracellular vesicles promote liver metastasis by activating hepatic stellate cells and remodelling the tumour microenvironment.
Zhao S; Mi Y; Zheng B; Wei P; Gu Y; Zhang Z; Xu Y; Cai S; Li X; Li D
J Extracell Vesicles; 2022 Jan; 11(1):e12186. PubMed ID: 35041299
[TBL] [Abstract][Full Text] [Related]
3. Liver metastasis from colorectal cancer: pathogenetic development, immune landscape of the tumour microenvironment and therapeutic approaches.
Wang Y; Zhong X; He X; Hu Z; Huang H; Chen J; Chen K; Zhao S; Wei P; Li D
J Exp Clin Cancer Res; 2023 Jul; 42(1):177. PubMed ID: 37480104
[TBL] [Abstract][Full Text] [Related]
4. The Therapeutic Potential of Tackling Tumor-Induced Dendritic Cell Dysfunction in Colorectal Cancer.
Subtil B; Cambi A; Tauriello DVF; de Vries IJM
Front Immunol; 2021; 12():724883. PubMed ID: 34691029
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of colorectal liver metastasis development.
Shasha T; Gruijs M; van Egmond M
Cell Mol Life Sci; 2022 Nov; 79(12):607. PubMed ID: 36436127
[TBL] [Abstract][Full Text] [Related]
6. The tumor microenvironment of colorectal cancer metastases: opportunities in cancer immunotherapy.
Kamal Y; Schmit SL; Frost HR; Amos CI
Immunotherapy; 2020 Oct; 12(14):1083-1100. PubMed ID: 32787587
[TBL] [Abstract][Full Text] [Related]
7. Mucosa-associated invariant T cells infiltrate hepatic metastases in patients with colorectal carcinoma but are rendered dysfunctional within and adjacent to tumor microenvironment.
Shaler CR; Tun-Abraham ME; Skaro AI; Khazaie K; Corbett AJ; Mele T; Hernandez-Alejandro R; Haeryfar SMM
Cancer Immunol Immunother; 2017 Dec; 66(12):1563-1575. PubMed ID: 28798979
[TBL] [Abstract][Full Text] [Related]
8. Cancer-associated stroma reveals prognostic biomarkers and novel insights into the tumour microenvironment of colorectal cancer and colorectal liver metastases.
Brown KM; Xue A; Smith RC; Samra JS; Gill AJ; Hugh TJ
Cancer Med; 2022 Jan; 11(2):492-506. PubMed ID: 34874125
[TBL] [Abstract][Full Text] [Related]
9. The progress of non-alcoholic fatty liver disease as the risk of liver metastasis in colorectal cancer.
Lv Y; Patel N; Zhang HJ
Expert Rev Gastroenterol Hepatol; 2019 Dec; 13(12):1169-1180. PubMed ID: 31774328
[No Abstract] [Full Text] [Related]
10. Immune phenotypic linkage between colorectal cancer and liver metastasis.
Liu Y; Zhang Q; Xing B; Luo N; Gao R; Yu K; Hu X; Bu Z; Peng J; Ren X; Zhang Z
Cancer Cell; 2022 Apr; 40(4):424-437.e5. PubMed ID: 35303421
[TBL] [Abstract][Full Text] [Related]
11. Possible Role of Cancer Stem Cells in Colorectal Cancer Metastasizing to the Liver.
Jiao ZY; Cao HT; Li YM
Curr Stem Cell Res Ther; 2016; 11(5):440-3. PubMed ID: 26832139
[TBL] [Abstract][Full Text] [Related]
12. Th17 Cells Secrete TWEAK to Trigger Epithelial-Mesenchymal Transition and Promote Colorectal Cancer Liver Metastasis.
Liu X; Wang X; Yang Q; Luo L; Liu Z; Ren X; Lei K; Li S; Xie Z; Zheng G; Zhang Y; Hao Y; Zhou Q; Hou Y; Fang F; Song W; Cui J; Ma J; Xie W; Shen S; Tang C; Peng S; Yu J; Kuang M; Song X; Wang F; Xu L
Cancer Res; 2024 Apr; 84(8):1352-1371. PubMed ID: 38335276
[TBL] [Abstract][Full Text] [Related]
13. Single-cell transcriptome analysis reveals tumor immune microenvironment heterogenicity and granulocytes enrichment in colorectal cancer liver metastases.
Zhang Y; Song J; Zhao Z; Yang M; Chen M; Liu C; Ji J; Zhu D
Cancer Lett; 2020 Feb; 470():84-94. PubMed ID: 31610266
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Targeting of the Tumour Microenvironment in Metastatic Colorectal Cancer.
Dmello RS; To SQ; Chand AL
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669775
[TBL] [Abstract][Full Text] [Related]
15. Bcl-xL mediates interferon-beta secretion by protease-activated receptor 2 deficiency through the mitochondrial permeability transition pore in colorectal cancer metastasis.
Ma J; Liu Y; Yuan J; Ma Y; Zhao X; Chen K; Zhang X; Zhang F; Wang H
Cancer Lett; 2024 Jan; 580():216483. PubMed ID: 37972702
[TBL] [Abstract][Full Text] [Related]
16. Tumor inherent interferons: Impact on immune reactivity and immunotherapy.
Brockwell NK; Parker BS
Cytokine; 2019 Jun; 118():42-47. PubMed ID: 29681426
[TBL] [Abstract][Full Text] [Related]
17. THBS1 facilitates colorectal liver metastasis through enhancing epithelial-mesenchymal transition.
Liu X; Xu D; Liu Z; Li Y; Zhang C; Gong Y; Jiang Y; Xing B
Clin Transl Oncol; 2020 Oct; 22(10):1730-1740. PubMed ID: 32052380
[TBL] [Abstract][Full Text] [Related]
18. IL-33 promotes growth and liver metastasis of colorectal cancer in mice by remodeling the tumor microenvironment and inducing angiogenesis.
Zhang Y; Davis C; Shah S; Hughes D; Ryan JC; Altomare D; Peña MM
Mol Carcinog; 2017 Jan; 56(1):272-287. PubMed ID: 27120577
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of extracellular matrix proteins in three recurrent liver metastases of a single patient with colorectal cancer.
Voß H; Wurlitzer M; Smit DJ; Ewald F; Alawi M; Spohn M; Indenbirken D; Omidi M; David K; Juhl H; Simon R; Sauter G; Fischer L; Izbicki JR; Molloy MP; Nashan B; Schlüter H; Jücker M
Clin Exp Metastasis; 2020 Dec; 37(6):649-656. PubMed ID: 33099724
[TBL] [Abstract][Full Text] [Related]
20. Repression of let-7a cluster prevents adhesion of colorectal cancer cells by enforcing a mesenchymal phenotype in presence of liver inflammation.
Cheng L; Geng L; Dai B; Zheng T; Fu J; Qiao L; Cai W; Wang Y; Yang J
Cell Death Dis; 2018 May; 9(5):489. PubMed ID: 29695839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
